gamevac-combi
Vaccineexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
1
Earliest trial started Jul 20, 2017 (NCT03072030)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Approved for
Mechanism of action
- MarburgvirusImmunity, active
Marburgvirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gamevac-combi
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03333538 | Phase 1/Phase 2 (Phase 2) | Nov 3, 2017 | Government of Russia |
| NCT03072030 | Phase 4 | Jul 20, 2017 | Government of Russia |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Russia | Government | 2 | 2 | 2 | 2017 |
1 organizations
Page 1 / 1